Do Thiazide Diuretics Confer Specific Protection Against Strokes?
Authors:
- Franz H. MesserliFMFranz H. Messerli
- Ehud GrossmanEGEhud Grossman
- Anthony F. LeverALAnthony F. Lever
Open Access
- 24 November 2003
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 163 (21) , 2557-2560
Abstract
Several large studies have suggested that therapy with thiazide diuretics confers a particular benefit in reducing the risk of strokes that seem to be, at least to some extent, independent of the blood pressure–lowering effect. Such a cerebroprotective effect was documented not only with monotherapy but also when diuretics were used in combination with other drugs. The cerebroprotective effect does not seem to be shared by other drug classes, such as the β-blockers or the angiotensin-converting enzyme inhibitors, in patients without manifest cardiovascular disease. Since stroke is one of the most devastating sequelae of high blood pressure, our data strongly favor the use of low-dose diuretics either as initial therapy or in combination in all hypertensive patients at risk for cerebrovascular disease.Keywords
This publication has 12 references indexed in Scilit:
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 2002
- Non-AT1-receptor-mediated protective effect of angiotensin against acute ischaemic stroke in the gerbilJournal of the Renin-Angiotensin-Aldosterone System, 2001
- Antihypertensive Drug Therapies and the Risk of Ischemic StrokeArchives of internal medicine (1960), 2001
- International Trends in Mortality From Stroke, 1968 to 1994Stroke, 2000
- Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trialsThe Lancet, 2000
- Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trialThe Lancet, 1999
- Transient upregulation of the AT2 receptor mRNA level after global ischemia in the rat brainNeuropeptides, 1996
- Angiotensin AT2 Receptor Stimulation Increases Survival in Gerbils with Abrupt Unilateral Carotid LigationJournal of Cardiovascular Pharmacology, 1994
- MRC Trial of Treatment in Elderly HypertensivesClinical and Experimental Hypertension, 1993
- Angiotensin II decreases mortality rate in gerbils with unilateral carotid ligation.Stroke, 1986